Transaction in Own Shares by GSK plc

GSK plc announced on May 18, 2026, that it has purchased a total of 1,671,851 ordinary shares between May 11 and May 15, 2026, through its broker, Citigroup Global Markets Limited. These shares were bought as part of the company's existing buyback program and will be held as treasury shares. Following these transactions, GSK plc will hold 263,050,137 ordinary shares in treasury, with 4,053,167,539 ordinary shares in issue. The total number of voting rights in the company is now 4,053,167,539. The percentage of voting rights held in treasury is 6.49%. The announcement includes a full breakdown of individual share purchases made on the London Stock Exchange and CBOE Europe Limited, available via a provided link. This report is filed on Form 6-K.